Z-1099-2021 Class II Terminated

Recalled by Cytocell Ltd. — Cambridge, N/A

FDA device recall Z-1099-2021 was initiated by Cytocell Ltd. on Dec 22, 2020 and is designated Class II. Reason for recall: Users may observe very faint additional locus specific signals at 11q13. There is a low risk of a normal sample being reported as not normal in a resulting laboratory developed test (LDT) that… The recall status is terminated (terminated Jun 7, 2022). Affected quantity: 72.

Recall details

Product Type
Devices
Report Date
Feb 17, 2021
Initiation Date
Dec 22, 2020
Termination Date
Jun 7, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
72

Product description

Aquarius LPH 511-A CRLF2 Distal Probe Green, model no. LPH 511-A The CRLF2 Distal probe, labelled in green, consists of two probes (71kb and 131kb) that are situated distal (telomeric) to the CRLF2 gene

Reason for recall

Users may observe very faint additional locus specific signals at 11q13. There is a low risk of a normal sample being reported as not normal in a resulting laboratory developed test (LDT) that utilizes the LPH511-A CRLF2 Distal Probe Green.

Distribution pattern

Domestic distribution to California, Illinois, Michigan, Minnesota, New Jersey, Texas, and Washington. Foreign distribution to Canada.

Code information

Lots 072240, 071390, and 072693

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1099-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1099-2021. Report a data issue: hello@regdatalab.com.